American College of Cardiology Renews Partnership with Elsevier

Date: August 1st, 2017

Elsevier and the American College of Cardiology’s are pleased to announce the renewal of their long-standing partnership to publish the JACC Family of Journals.  As a leading global, widely read Cardiology journal, JACC is an invaluable resource for clinicians and researchers alike. JACC maintains one of the highest impact factor in Cardiovascular Medicine and three of the sister titles including JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging and JACC: Heart Failure also rank in the top 10 journals in Cardiology and ahead of their closest competitors. JACC: Clinical Electrophysiology and JACC: Basic to Translational Science are the newest titles and are quickly gaining similar prestige.

Leading the Field in Impact and Readership

The American College of Cardiology has built a reputation for the quality and relevance of their JACC publications.  JACC continue to be a leader the field of Cardiology with an Impact Factor reaching 19.896 for 2016.  The more recently launched JACC journals also continue to grow in relevance and importance with JACC: Cardiovascular Interventions (Impact Factor 8.841), JACC: Cardiovascular Imaging (Impact Factor 10.189), JACC: Clinical Electrophysiology and JACC: Heart Failure (Impact Factor 8.493). The titles publish peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the art papers, review articles, and editorials interpreting and commenting on the research presented. Moreover, the journal editors and editorial staffs are among the most widely respected physicians in their field, led by the renowned Dr. Valentin Fuster as the Editor in Chief of JACC. There is no more prestigious or widely read family of journals in the field and they are the cornerstone of any Cardiology program.  

No longer in collections and with new pricing

For 2018, JACC - as well as JACC: Cardiovascular Imaging, JACC: Cardiovascular Interventions, JACC: Clinical Electrophysiology and JACC: Heart Failure --will no longer be available in Elsevier’s subject and freedom collections and will need to be ordered separately.  The subscription prices of the JACC Journals will also be priced in accordance with their influence and importance in the cardiovascular medicine and research worldwide and in keeping with the strong growth in issues, articles and features across much of the program

What prompts this change

In recent years, the ACC has made a major investment in developing a string of new journals ensuring that the highest quality research is published to exacting standards.  Each new journal helps to raise standards and give clinicians and researchers access to the very finest work.  Historically, ACC titles have been comparatively underpriced and to develop new titles and maintain quality, it has become necessary to increase prices.  To maintain and continue this considerable investment, ACC must ensure that its journal publishing activity covers its costs and gives the College the opportunity to reinvest.  Broad access to the ACC journals remains very important to the College so, in addition to aligning the JACC journals prices with their relevance the market, a package price for the JACC Family of Journals will be introduced at discounted rates to facilitate access to the full breadth of premium content offered by JACC.

Advertisement